DNA X, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
DNA X, Inc. (SONM) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $4.19 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2025-03-31
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2021-03-31 was $0.75, a 13.79% decline year-over-year.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2020-03-31 was $0.87, a 16.00% increase year-over-year.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2019-03-31 was $0.75.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $4.19.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2021 was $7.50, a 6.23% increase from fiscal 2020.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2020 was $7.06, a 730.59% increase from fiscal 2019.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2019 was $0.85, a 24.11% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $4.19 10-K · filed 2025-03-31 | $0.42 10-K · filed 2024-03-27 | |||
| 2023-09-30 | $0.42 10-Q · filed 2023-11-14 | ||||
| 2021-12-31 | $7.50 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $7.50 10-Q/A · filed 2022-06-29 | ||||
| 2021-06-30 | $0.75 10-Q/A · filed 2022-06-29 | ||||
| 2021-03-31 | $0.75 10-Q · filed 2021-05-11 | ||||
| 2020-12-31 | $7.06 10-K/A · filed 2022-06-29 | $0.71 10-K · filed 2021-03-18 | |||
| 2020-09-30 | $0.83 10-Q · filed 2020-11-12 | ||||
| 2020-06-30 | $0.83 10-Q · filed 2020-08-12 | ||||
| 2020-03-31 | $0.87 10-Q · filed 2020-05-14 | ||||
| 2019-12-31 | $0.85 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $0.81 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | $0.77 10-Q · filed 2019-08-13 | ||||
| 2019-03-31 | $0.75 10-Q · filed 2019-06-24 | ||||
| 2018-12-31 | $1.12 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CLEARONE INC (CLRO) | United States | $0.009B | |
| FRANKLIN WIRELESS CORP (FKWL) | United States | $0.028B | -61.80 |
| FiEE, Inc. (FIEE) | Japan | $0.033B | 8.06 |
| Clearfield, Inc. (CLFD) | United States | $0.415B | -74.88 |
| ADTRAN Holdings, Inc. (ADTN) | United States | $0.565B | -43.25 |
| Fabrinet (FN) | $14.287B | 39.79 | |
| CIENA CORP (CIEN) | United States | $50.874B | 81.72 |